The relationship between the concentration of Tau protein in cerebrospinal fluid and dementia
Kong Fan
Abstract
Kong Fan
Abstract
Objective:To study the relationship between the concentration of the Tau protein in cerebrospinal fluid (CSF) and dementia and to evaluate it′s significance in diagnosis of Alzheimer′s disease (AD). Methods:The concentration of the Tau protein in CSF were measured and comparatively analysed using sandwich ELISA. The patients were divided into 4 groups, including 15 cases of AD, 15 cases of vascular dementia (VD), 20 cases of non dementia neurologic diseases (ND) and 20 cases of normal control (NC). Results:The concentration of the Tau protein in CSF of AD were significantly higher than those of other groups ( P 0.01). There was no statistical difference among 3 clinical stages of AD ( P 0.05), either no difference found between the normal Tau protein group and elevated Tau protein group in the total CSF protein ( P 0.05). The linear correlation analysis based on the total protein in CSF revealed that there was no correlation in ND group ( r =0.16, P 0.05). The linear correlation analysis on age showed positive correlation in NC group ( r =0.53, P 0.05). Conclusion: The measurement of the Tau protein in CSF is refered to the clinical diagnosis of AD.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To study the relationship between the concentration of the Tau protein in cerebrospinal fluid (CSF) and dementia and to evaluate it′s significance in diagnosis of Alzheimer′s disease (AD). Methods:The concentration of the Tau protein in CSF were measured and comparatively analysed using sandwich ELISA. The patients were divided into 4 groups, including 15 cases of AD, 15 cases of vascular dementia (VD), 20 cases of non dementia neurologic diseases (ND) and 20 cases of normal control (NC). Results:The concentration of the Tau protein in CSF of AD were significantly higher than those of other groups ( P 0.01). There was no statistical difference among 3 clinical stages of AD ( P 0.05), either no difference found between the normal Tau protein group and elevated Tau protein group in the total CSF protein ( P 0.05). The linear correlation analysis based on the total protein in CSF revealed that there was no correlation in ND group ( r =0.16, P 0.05). The linear correlation analysis on age showed positive correlation in NC group ( r =0.53, P 0.05). Conclusion: The measurement of the Tau protein in CSF is refered to the clinical diagnosis of AD.
Key concepts: Cerebrospinal fluid, Dementia, Vascular dementia, Tau protein, Internal medicine, Correlation, Positive correlation, Linear correlation